ERalpha degrader-2 is a selective and potent estrogen receptor (SERD) degrader with anticancer activity, inhibits ERalpha, and has an EC50 value for estrogen receptor degradation of 0.3 nM.ERalpha degrader-2 can be used for the prevention and treatment of HER-positive breast cancer.